125 related articles for article (PubMed ID: 8305516)
1. 2',5'-Oligoadenylate:antisense chimeras--synthesis and properties.
Lesiak K; Khamnei S; Torrence PF
Bioconjug Chem; 1993; 4(6):467-72. PubMed ID: 8305516
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of chimeric 2-5A-DNA oligonucleotides.
Player MR; Torrence PF
Curr Protoc Nucleic Acid Chem; 2001 May; Chapter 4():Unit 4.4. PubMed ID: 18428851
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of antisense oligonucleotides carrying modified 2-5A molecules at their 5'-termini and their properties.
Ueno Y; Kato Y; Okatani S; Ishida N; Nakanishi M; Kitade Y
Bioconjug Chem; 2003; 14(3):690-6. PubMed ID: 12757397
[TBL] [Abstract][Full Text] [Related]
4. Correlation of selective modifications to a 2',5'-oligoadenylate-3',5'-deoxyribonucleotide antisense chimera with affinity for the target nucleic acid and with ability to activate RNase L.
Xiao W; Li G; Maitra RK; Maran A; Silverman RH; Torrence PF
J Med Chem; 1997 Apr; 40(8):1195-200. PubMed ID: 9111293
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of double-headed 2-5A-antisense chimeras and their ability to activate human RNase L.
Ueno Y; Okatani S; Yamada Y; Kitade Y
Bioorg Med Chem Lett; 2003 Nov; 13(22):3959-61. PubMed ID: 14592484
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of the antisense oligonucleotides carrying the modified 2-5A molecules at their 5'-termini and their properties.
Ueno Y; Kato Y; Okatani S; Kitade Y
Nucleic Acids Res Suppl; 2002; (2):45-6. PubMed ID: 12903097
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of composite nucleic acids containing 2', 5'-oligoriboadenylate linked to antisense DNA.
Xiao W; Player MR; Li G; Zhang W; Lesiak K; Torrence PF
Antisense Nucleic Acid Drug Dev; 1996; 6(4):247-58. PubMed ID: 9012860
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and properties of second-generation 2-5A-antisense chimeras with enhanced resistance to exonucleases.
Li G; Xiao W; Torrence PF
J Med Chem; 1997 Aug; 40(18):2959-66. PubMed ID: 9288179
[TBL] [Abstract][Full Text] [Related]
9. Targeting RNA for degradation with a (2'-5')oligoadenylate-antisense chimera.
Torrence PF; Maitra RK; Lesiak K; Khamnei S; Zhou A; Silverman RH
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1300-4. PubMed ID: 7679499
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of double-headed 2-5A-antisense chimeras and their ability to activate human RNase L.
Ueno Y; Okatani S; Yamada Y; Kitade Y
Nucleic Acids Res Suppl; 2003; (3):63-4. PubMed ID: 14510381
[TBL] [Abstract][Full Text] [Related]
11. 2-5A-DNA conjugate inhibition of respiratory syncytial virus replication: effects of oligonucleotide structure modifications and RNA target site selection.
Barnard DL; Sidwell RW; Xiao W; Player MR; Adah SA; Torrence PF
Antiviral Res; 1999 Apr; 41(3):119-34. PubMed ID: 10320045
[TBL] [Abstract][Full Text] [Related]
12. 2,5-oligoadenylate-peptide nucleic acids (2-5A-PNAs) activate RNase L.
Verheijen JC; van der Marel GA; van Boom JH; Bayly SF; Player MR; Torrence PF
Bioorg Med Chem; 1999 Mar; 7(3):449-55. PubMed ID: 10220031
[TBL] [Abstract][Full Text] [Related]
13. Methods for the characterization of phosphatase-stabilized 2-5A-antisense chimeras.
Player MR; Xiao W; Cramer H; Torrence PF
Bioconjug Chem; 1998; 9(1):137-42. PubMed ID: 9460557
[TBL] [Abstract][Full Text] [Related]
14. Chemistry and biochemistry of 2',5'-oligoadenylate-based antisense strategy.
Adah SA; Bayly SF; Cramer H; Silverman RH; Torrence PF
Curr Med Chem; 2001 Aug; 8(10):1189-212. PubMed ID: 11472236
[TBL] [Abstract][Full Text] [Related]
15. Blockage of NF-kappa B signaling by selective ablation of an mRNA target by 2-5A antisense chimeras.
Maran A; Maitra RK; Kumar A; Dong B; Xiao W; Li G; Williams BR; Torrence PF; Silverman RH
Science; 1994 Aug; 265(5173):789-92. PubMed ID: 7914032
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 2-5As possessing base-modified adenosines and their activities to human recombinant RNase L.
Kitade Y; Tanida Y; Tuboi T; Yoshimura A; Nakanishi M; Yatome C
Nucleic Acids Symp Ser; 2000; (44):29-30. PubMed ID: 12903252
[TBL] [Abstract][Full Text] [Related]
17. Targeting RNase L to human immunodeficiency virus RNA with 2-5A-antisense.
Player MR; Maitra RK; Silverman RH; Torrence PF
Antivir Chem Chemother; 1998 May; 9(3):225-31. PubMed ID: 9875401
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 2',5'-oligoadenylate analogs possessing a linker moiety in the place of the second adenosine and their ability to activate human RNase L.
Nakamura T; Ito Y; Mochizuki M; Ueno Y; Kitade Y
Nucleic Acids Symp Ser (Oxf); 2007; (51):449-50. PubMed ID: 18029780
[TBL] [Abstract][Full Text] [Related]
19. 4'-Thio-RNA: synthesis of mixed base 4'-thio-oligoribonucleotides, nuclease resistance, and base pairing properties with complementary single and double strand.
Leydier C; Bellon L; Barascut JL; Morvan F; Rayner B; Imbach JL
Antisense Res Dev; 1995; 5(3):167-74. PubMed ID: 8785472
[TBL] [Abstract][Full Text] [Related]
20. A new and potent 2-5A analogue which does not require a 5'-polyphosphate to activate mouse L-cell RNase L.
Torrence PF; Brozda D; Alster DK; Pabuccuoglu A; Lesiak K
Antiviral Res; 1992 Jun; 18(3-4):275-89. PubMed ID: 1416909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
